z-logo
Premium
Effect of Bcl‐x L overexpression on lactate metabolism in chinese hamster ovary cells producing antibody
Author(s) -
Ha Tae Kwang,
Jeon Min Kyoung,
Yu Da young,
Lee Gyun Min
Publication year - 2013
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1002/btpr.1805
Subject(s) - chinese hamster ovary cell , hexokinase , lactate dehydrogenase , bcl xl , cell culture , metabolism , carbohydrate metabolism , lactate dehydrogenase a , microbiology and biotechnology , biology , biochemistry , enzyme , apoptosis , chemistry , glycolysis , programmed cell death , genetics
Previously, overexpression of anti‐apoptotic proteins, such as E1B‐19K and Aven, was reported to alter lactate metabolism of CHO cells in culture. To investigate the effect of Bcl‐x L , a well‐known anti‐apoptotic protein, on lactate metabolism of recombinant CHO (rCHO) cells, two antibody‐producing rCHO cell lines with regulated Bcl‐x L overexpression (CS13*‐0.02‐off‐Bcl‐x L and CS13*‐1.00‐off‐Bcl‐x L ) were established using the Tet‐off system. When cells were cultivated without Bcl‐x L overexpression, the specific lactate production rate (q Lac ) of CS13*‐0.02‐off‐Bcl‐x L and CS13*‐1.00‐off‐Bcl‐x L were 7.32 ± 0.37 and 6.78 ± 0.56 pmol/cell/day, respectively. Bcl‐x L overexpression, in the absence of doxycycline, did not affect the q Lac of either cell line, though it enhanced the viability during cultures. Furthermore, activities of the enzymes related to glucose and lactate metabolism, such as hexokinase, glucose‐6‐phosphate dehydrogenase, lactate dehydrogenases, and alanine aminotransferase, were not affected by Bcl‐x L overexpression either. Taken together, Bcl‐x L overexpression showed no significant effect on the lactate metabolism of rCHO cells. © 2013 American Institute of Chemical Engineers Biotechnol. Prog ., 29:1594–1598, 2013

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here